6WA5

Solution NMR Structure of the G4L/Q5K/G6S (NOS) Unmyristoylated Feline Immunodeficiency Virus Matrix Protein

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H NOESY	50 mM sodium phosphate, 10 mM DTT, 5 mM sodium chloride, 300 uM Unmyristoylated G4L/Q5K/G6S (NOS) Feline Immunodeficiency Virus Matrix Protein	100% D2O	5 mM	8	1 atm	298	Bruker DMX 600
2	2D 1H-1H NOESY	50 mM sodium phosphate, 10 mM DTT, 5 mM sodium chloride, 300 uM Unmyristoylated G4L/Q5K/G6S (NOS) Feline Immunodeficiency Virus Matrix Protein	100% D2O	5 mM	5	1 atm	298	Bruker DMX 600
3	2D 1H-15N HSQC	50 mM sodium phosphate, 10 mM DTT, 5 mM sodium chloride, 4 g/L glucose, 1 g/L [U-99% 15N] ammonium chloride, 300 uM [U-15N] Unmyristoylated G4L/Q5K/G6S (NOS) Feline Immunodeficiency Virus Matrix Protein	90% H2O/10% D2O	5 mM	8	1 atm	298	Bruker DMX 600
4	2D 1H-15N HSQC	50 mM sodium phosphate, 10 mM DTT, 5 mM sodium chloride, 4 g/L glucose, 1 g/L [U-99% 15N] ammonium chloride, 300 uM [U-15N] Unmyristoylated G4L/Q5K/G6S (NOS) Feline Immunodeficiency Virus Matrix Protein	90% H2O/10% D2O	5 mM	5	1 atm	298	Bruker DMX 500
5	3D CBCA(CO)NH	50 mM sodium phosphate, 10 mM DTT, 5 mM sodium chloride, 4 g/L [U-99% 13C] glucose, 1 g/L [U-99% 15N] ammonium chloride, 300 uM [U-13C; U-15N] Unmyristoylated G4L/Q5K/G6S (NOS) Feline Immunodeficiency Virus Matrix Protein	90% H2O/10% D2O	5 mM	8	1 atm	298	Bruker DMX 600
6	3D CBCA(CO)NH	50 mM sodium phosphate, 10 mM DTT, 5 mM sodium chloride, 4 g/L [U-99% 13C] glucose, 1 g/L [U-99% 15N] ammonium chloride, 300 uM [U-13C; U-15N] Unmyristoylated G4L/Q5K/G6S (NOS) Feline Immunodeficiency Virus Matrix Protein	90% H2O/10% D2O	5 mM	5	1 atm	298	Bruker DMX 600
7	3D HNCACB	50 mM sodium phosphate, 10 mM DTT, 5 mM sodium chloride, 4 g/L [U-99% 13C] glucose, 1 g/L [U-99% 15N] ammonium chloride, 300 uM [U-13C; U-15N] Unmyristoylated G4L/Q5K/G6S (NOS) Feline Immunodeficiency Virus Matrix Protein	90% H2O/10% D2O	5 mM	8	1 atm	298	Bruker DMX 600
8	3D HNCACB	50 mM sodium phosphate, 10 mM DTT, 5 mM sodium chloride, 4 g/L [U-99% 13C] glucose, 1 g/L [U-99% 15N] ammonium chloride, 300 uM [U-13C; U-15N] Unmyristoylated G4L/Q5K/G6S (NOS) Feline Immunodeficiency Virus Matrix Protein	90% H2O/10% D2O	5 mM	5	1 atm	298	Bruker DMX 600
9	3D HNCO	50 mM sodium phosphate, 10 mM DTT, 5 mM sodium chloride, 4 g/L [U-99% 13C] glucose, 1 g/L [U-99% 15N] ammonium chloride, 300 uM [U-13C; U-15N] Unmyristoylated G4L/Q5K/G6S (NOS) Feline Immunodeficiency Virus Matrix Protein	90% H2O/10% D2O	5 mM	8	1 atm	298	Bruker DMX 600
10	3D HNCO	50 mM sodium phosphate, 10 mM DTT, 5 mM sodium chloride, 4 g/L [U-99% 13C] glucose, 1 g/L [U-99% 15N] ammonium chloride, 300 uM [U-13C; U-15N] Unmyristoylated G4L/Q5K/G6S (NOS) Feline Immunodeficiency Virus Matrix Protein	90% H2O/10% D2O	5 mM	5	1 atm	298	Bruker DMX 600
11	3D HN(CA)CO	50 mM sodium phosphate, 10 mM DTT, 5 mM sodium chloride, 4 g/L [U-99% 13C] glucose, 1 g/L [U-99% 15N] ammonium chloride, 300 uM [U-13C; U-15N] Unmyristoylated G4L/Q5K/G6S (NOS) Feline Immunodeficiency Virus Matrix Protein	90% H2O/10% D2O	5 mM	8	1 atm	298	Bruker DMX 600
12	3D HN(CA)CO	50 mM sodium phosphate, 10 mM DTT, 5 mM sodium chloride, 4 g/L [U-99% 13C] glucose, 1 g/L [U-99% 15N] ammonium chloride, 300 uM [U-13C; U-15N] Unmyristoylated G4L/Q5K/G6S (NOS) Feline Immunodeficiency Virus Matrix Protein	90% H2O/10% D2O	5 mM	5	1 atm	298	Bruker DMX 600
13	3D 1H-15N NOESY	50 mM sodium phosphate, 10 mM DTT, 5 mM sodium chloride, 4 g/L glucose, 1 g/L [U-99% 15N] ammonium chloride, 300 uM [U-15N] Unmyristoylated G4L/Q5K/G6S (NOS) Feline Immunodeficiency Virus Matrix Protein	90% H2O/10% D2O	5 mM	8	1 atm	298	Bruker DMX 600
14	3D 1H-15N NOESY	50 mM sodium phosphate, 10 mM DTT, 5 mM sodium chloride, 4 g/L glucose, 1 g/L [U-99% 15N] ammonium chloride, 300 uM [U-15N] Unmyristoylated G4L/Q5K/G6S (NOS) Feline Immunodeficiency Virus Matrix Protein	90% H2O/10% D2O	5 mM	5	1 atm	298	Bruker DMX 500
15	4D HSQC-NOESY-HMQC	50 mM sodium phosphate, 10 mM DTT, 5 mM sodium chloride, 4 g/L [U-99% 13C] glucose, 1 g/L [U-99% 15N] ammonium chloride, 300 uM [U-13C; U-15N] Unmyristoylated G4L/Q5K/G6S (NOS) Feline Immunodeficiency Virus Matrix Protein	90% H2O/10% D2O	5 mM	8	1 atm	298	Bruker DMX 600
16	4D HMQC-NOESY-HMQC	50 mM sodium phosphate, 10 mM DTT, 5 mM sodium chloride, 4 g/L [U-99% 13C] glucose, 1 g/L ammonium chloride, 300 uM [U-13C] Unmyristoylated G4L/Q5K/G6S (NOS) Feline Immunodeficiency Virus Matrix Protein	100% D2O	5 mM	8	1 atm	298	Bruker DMX 600
17	2D 1H-13C HMQC	50 mM sodium phosphate, 10 mM DTT, 5 mM sodium chloride, 300 uM Unmyristoylated G4L/Q5K/G6S (NOS) Feline Immunodeficiency Virus Matrix Protein	100% D2O	5 mM	8	1 atm	298	Bruker DMX 600
18	2D 1H-13C HMQC	50 mM sodium phosphate, 10 mM DTT, 5 mM sodium chloride, 300 uM Unmyristoylated G4L/Q5K/G6S (NOS) Feline Immunodeficiency Virus Matrix Protein	100% D2O	5 mM	5	1 atm	298	Bruker DMX 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DMX	600
2	Bruker	DMX	500

NMR Refinement
Method	Details	Software
na		CYANA

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	160
Conformers Submitted Total Number	20
Representative Model	1 (target function)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin		Bruker Biospin
2	processing	NMRFx		Johnson, One Moon Scientific
3	processing	NMRDraw		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
4	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
5	chemical shift assignment	NMRView		Johnson, One Moon Scientific
6	peak picking	NMRView		Johnson, One Moon Scientific
7	data analysis	NMRView		Johnson, One Moon Scientific
8	refinement	CYANA		Guntert, Mumenthaler and Wuthrich
9	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.